Rhythm Biosciences Limited is an Australian medical diagnostics company that specializes in developing and commercializing cutting-edge technology for the early detection of colorectal cancer. The company's flagship product, ColoSTAT, is a groundbreaking blood test that is set to significantly improve the detection and treatment of this deadly disease. Since its incorporation in 2017, Rhythm Biosciences Limited has established itself as a transformative force in the healthcare industry, with its innovative approach earning it a reputation as a company to watch. With its headquarters located in Parkville, Australia, Rhythm Biosciences Limited is poised to make a major impact on the global healthcare scene in the years to come.
Rhythm Biosciences Limited's ticker is RHY
The company's shares trade on the ASX stock exchange
They are based in Parkville, Australia
There are 11-50 employees working at Rhythm Biosciences Limited
It is https://www.rhythmbio.com/
Rhythm Biosciences Limited is in the Healthcare sector
Rhythm Biosciences Limited is in the Biotechnology industry
The following five companies are Rhythm Biosciences Limited's industry peers: